Initiator-free injectable hydrogels are very interesting for drug and/or cell delivery applications, since they can be administered in a minimally invasive way, without recurring to chemical initiators that could be harmful. In the current work, oxidized dextran crosslinked (dexOx) with adipic acid dihydrazide (AAD) hydrogels were further characterized and tuned to produce formulations, having in sight an injectable ocular formulation for the possible treatment of posterior eye diseases. The gelation rate and the hydrogels dissolution profile were shown to be dependent on the balance between the dextran oxidation degree, and both components concentration. On the in vitro studies, rabbit corneal endothelial cells were seeded on the hydrogels, to assess cytotoxicity. Hydrogels prepared with low oxidized dextrans were able to promote cell adhesion and proliferation to confluence in just 24 hours, while higher oxidized samples promoted cell adhesion and proliferation, but without achieving confluence. Cell viability studies were performed using MTS assays to verify the non-cytotoxicity of hydrogels and their degradation byproducts, rendering these formulations attractive for further in vivo studies.
Introduction
Ocular diseases of the posterior eye segment are the most common cause of visual disorders in industrialized countries 1 . These illnesses include, for example, cataracts, diabetic retinopathy, macular degeneration associated with aging and retinitis pigmentosa 1, 2 . The visual disorders cause discomfort, anxiety and fear of losing the vision in patients.
Until now, ocular drug market is dominated by drugs, which were conceived to treat illnesses that affect the anterior eye segment, such medicines include: antibiotics, anti-inflammatory agents or antiglaucoma drugs, usually as eye drop formulations 1, 3 . These topical applications, in the form of eye drops, are ineffective in many cases, due mainly to the drainage system of the eye, which leads to poor ocular bioavailability 4 . New drugs have been developed to reach the posterior eye segment, although, most of them are administered through repeated intravitreal injections. This method is associated with complications such as pain, increased intraocular pressure, retinal detachment and endophtalmitis (which may lead to blindness). New methods of drug delivery, more secure, efficient, comfortable and with prolonged activity are needed, to minimize the number of injections. Currently, there are systems of controlled drug delivery on the market or being tested, such as implants, hydrogels and colloids 1 .
Hydrogels are hydrophilic polymer networks, which may absorb up to thousands of times their dry weight in water. Hydrogels may be chemically stable or they may degrade and eventually disintegrate and dissolve. They are called "reversible" or "physical" gels when the networks are held together by molecular entanglements, and/or secondary forces including ionic, H-bonding or hydrophobic forces.
Hydrogels are called "permanent" or "chemical" gels when they are covalently-crosslinked networks 5 .
Recently, Van Tomme and collaborators compiled the different strategies used in producing dextran-based hydrogels, demonstrating dextran as a very versatile starting polymer for hydrogel synthesis 6 . Furthermore, pharmaceuticals and various potential therapeutic agents can easily be incorporated and its release profile controlled. Recently, human embryonic stem-cell encapsulation was also successfully achieved in bioactive hydrogels of dextran-acrylate 7 .
Dextran is biocompatible and can be degraded through the action of dextranases in various organs in the human body, including liver, spleen, kidney and colon 8 .
Dextran oxidation by sodium periodate is an easy and well-known way to functionalize dextran with aldehyde moieties 9 . This chemical functionality has been widely tested to conjugate N-nucleophiles, due to their fast and almost complete reaction 10 . This approach has been tested on the synthesis of prodrugs 11 , as a spacer in enzyme immobilization 12 or for growth factor controlled release 13 . On the preparation of hydrogels, different aminated crosslinkers, like chitosan 14, 15 , gelatin 16 , 8-arm PEG amine 17 or polyhydrazides 18 have been used to yield chemical initiator-free formulations.
Recently, we described an injectable formulation composed of oxidized dextran (dexOx) crosslinked with adipic acid dihydrazide (AAD) 19 . The dexOx with 15% oxidation degree (OD) was crosslinked with AAD, forming a gel within 2-4 minutes, depending on the AAD concentration used. The obtained hydrogels were characterized by their mechanical properties (7 -32 kPa), swelling and degradation (9 to 23 days) behavior under physiologic conditions.
In this work, oxidized dextran, with various OD, was studied in order to improve the control of the system properties. The influence of dextran OD and concentration in the solution viscosity was monitored. We observed that the hydrogel swelling and dissolution could also be controlled by the dextran oxidation degree and that the dissolution profile could be extended for more than 2 months, improving the previous studied formulation. Cell toxicity assays were carried out in 96-well plates with different dexOx's hydrogels. Cell viability studies were performed using rabbit corneal endothelial cells, which were seeded on top of the dexOx's hydrogels. The cell adhesion and growth was visualized by optical microscopy and dehydrogenase activity of cells was evaluated by reduction of the MTS reagent. Essential Medium Eagle, penicillin G, streptomycin, and trypsin were purchased from Sigma (Sintra, Portugal). Foetal bovine serum was purchased from Biochrom AG (Berlin, Germany). The 3-[4,5-
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(MTS) and electron coupling reagent (phenazine methosulfate; PMS) were purchased from Promega.
T-flasks and 96 well plates were purchased from Nunc (Denmark).
Dextran oxidation
An aqueous solution of dextran (1 g; 0.125%, w/v) was oxidized with 2 mL of sodium periodate solution with different concentrations (33 -264 mg/mL) to yield theoretical oxidations from 5 to 40%, at room temperature. The reaction was stopped after 4 hours. The resulting solution was dialyzed for 3 days against water, using a dialysis tube with a MWCO 12-14,000 Da, and then lyophilized (Snidjers Scientific type 2040, Tillburg, Holland). The scale-up of the reaction was done using the same procedure albeit using 30 g of dextran and a calculated amount of periodate to yield a theoretical oxidation of 5, 10, 25 and 40%.
Nuclear magnetic resonance (NMR) and size exclusion chromatography (SEC)
The OD of dexOx is defined as the number of oxidized residues per 100 glucose residues (OD refers to the theoretical value unless otherwise stated) and quantified by using tBC 20, 21 Size exclusion chromatography was performed in a HPLC system composed of a degasser and a
WellChrom Maxi-Star k-1000 pump (Knauer), coupled to a LS detector (evaporative light scattering PL-EMD 960) and one column (PL aquagel-OH Mixed 8 !m) from Polymer Laboratories. The whole system was kept at room temperature and the eluent used was KNO 3 (0.001 M; pH 3.9) at a flow rate of 0.4 mL/min. Samples and standards were dissolved in the eluent at 4-6 mg/mL (Fluka Chemie AG, dextran standards from 12 -80 kDa).
DexOx's solutions viscosity
Dextran and dexOx's solutions, with concentrations ranging from 10 to 30% (w/w) in PBS, were prepared and analyzed in a Brookfield Programmable D-II+ Viscometer with a S18 spindle, assisted by DVLoader v1.0 software. The chamber temperature was controlled by an external bath to 25 ºC, and the chamber was loaded with 8 mL of solution.
Hydrogel preparation and characterization
The several oxidized dextrans were dissolved in different concentrations; dexOx 5% (D5) and 10%
(D10) solutions were used at 30% (w/w) and dexOx 25% (D25) at 20% (w/w), in aqueous solvent (PBS) at 37 ºC until a liquid solution was obtained and then kept at 5 to 8 ºC, until further use. Then, 250 !L of a given dexOx solution was mixed with 250 !L of a given AAD solution on homemade
Teflon® molds and let to crosslink never less than 2 hours (except for the D5 hydrogels, which were let to cure over night). The AAD concentrations used are calculated based on a given molar percentage of dextran residues. The hydrogels nomenclature is as follows: dexOx 5% + AAD 5% -D5A5; and so forth.
Dynamic swelling experiments
DexOx hydrogels, after being prepared and weighted (W i ), were immersed in PBS (ca. 5 mL) in 6-wells cell culture plates, at 37 ºC. At regular time intervals, they were removed from the aqueous solution, blotted in filter paper, weighted (W t ) and returned to the original well while PBS was replaced.
Swelling Index:
Rheological analysis
Rheological experiments were carried out using the parallel plate geometry (20 mm diameter, steel)
of a Haake Rheostress RS 1. On the calculation of gelation period, both solutions (190 !L each) were mixed on the bottom plate, and the upper plate was positioned at a gap of 1 mm (after gap optimization). This procedure took around 20 seconds after which the experiment was started at low frequency (0.5 Hz) and stress (0.1 Pa), to avoid interference with the network formation. The gelation rate was followed and the gelation period was considered to be the crossover point between G' and G'' (G'=G'').
Cell source and growth
Corneal endothelial cells from rabbit were obtained as previously described 22 . Subsequently, cells
were platted in T-flasks of 25 cm 3 with Minimum Essential Medium Eagle (MEM) with heatinactivated foetal bovine serum (FBS, 10% v/v) and growth factors to do primary culture in agreement with the procedures previously described in the literature 23 . T-flasks with cells were incubated in a 5%
carbon dioxide humidified atmosphere at 37ºC. On day 3, the medium was changed and here after every three days. Six days after cells attained confluence.
After confluence was obtained, cells were sub-cultivated using 5 min incubation in 0.18 % trypsin
(1:250) and 5 mM EDTA. The free cells were added to an equal volume of culture medium. Following centrifugation, cells were resuspended in sufficient culture medium and seed in 96 well plates containing the biomaterials.
Cell culture and in vitro cytotoxicity studies
Two crosslinking degrees of AAD for each dexOx were selected and used on cytocompatibility tests. The oxidized dextran samples and AAD were either dissolved in PBS or in the appropriate cell culture medium, MEM.
Each formulation in the form of hydrogel was introduced (n=6), on wells of 96-wells cell culture plates, never exceeding 60 !L. The plates were irradiated for 30 minutes with UV, before being seeded with cells. Wells containing cells in culture medium without biomaterials were used as negative control (K-).
Ethanol 96% was added to wells containing both types of cells to have a positive control (K+). The samples were analysed using an Olympus CX41 optical microscope equipped with an Olympus SP-500 UZ digital camera.
Results and Discussion

DexOx characterization
Following previous work 19 , we characterized hydrogels made from dexOx with a wider range of oxidation degrees, crosslinked with different amounts of AAD. Dextran was oxidized by using sodium periodate at different percentages and characterized by 1 H-NMR. The oxidation degree was not estimated by the TNBS assay, due to the good correlation of the NMR titration with the colorimetric assay, as shown in previous work 19 . The tert-butyl carbazate titration, however, causes sample precipitation when reacted with high oxidation degree samples, not allowing NMR spectra acquisition (D40, Table 1 ). We suggest that this effect is caused by the large tert-butyl moiety and we hypothesized that a less bulky molecule, such as ethyl carbazate, would not cause sample precipitation.
In fact, both spectra are similar except for the ethyl protons peak which is sharper and slightly shifted upfield in comparison to the tert-butyl peak (spectra not shown). The real oxidation degree was calculated by taking into account the ratio between the integral of the peak at 7.3 ppm (arising from the carbazone group formed either with tBC or EtC) and the integral of the anomeric proton at 4.9
ppm. The oxidation degrees obtained with EtC were slightly higher (Table 1) than that obtained with tBC titration, which may suggest some difficulty of tBC to react further due to its bulkier moiety.
The dexOx number-average molecular weight (Mn), estimated by a SEC analysis, showed a clear decrease with increasing oxidation degree, but also an increasing polidispersity index (PDI), reflecting the higher range of dexOx molecular weights (Table 1) .
DexOx solutions viscosity
On the design of injectable hydrogel formulations, details, like viscosity characterization, become increasingly important, in order to choose the best syringe geometries and/or needle gauges. Generally, the hydrogel characteristics can be tailored by the feed concentration 14 , degree of polymer modification and in other cases, chemical initiators concentration 24 . This particular system involves the mixing of two equal-volume solutions, each of which, with its own reactive species, oxidized dextran residues and the dihydrazide. Thus, the formulations design has to take into account the feed concentration halving, of both solutions, after mixing.
Every dexOx sample, at any of the concentrations tested, showed a linear shear stress increase regarding the different shear rates, hence, a Newtonian behavior. For every concentration tested, across the different OD's, the obtained viscosities for each dexOx series show a natural trend directly related with the concentration, as can be observed on Figure 2A for dextran and D40. The OD influence on viscosity seems to have a higher effect, when the polymer concentration is high, but as the polymer solution is less concentrated, the viscosity tends to decrease and eventually be lower than the reference solution (original dextran).
Within the same concentration range, only the D25 viscosity falls below the dextran viscosity, but on the other hand, D40 has an extremely high viscosity reflecting the influence of the high reactivity, due to the high OD ( Figure 2B ).
We suggest that this effect is due to the molecular weight decrease with oxidation, which, below a certain concentration, counter-balances the crosslinking via hemiacetals ( Figure 1A ), decreasing the solution viscosity (Figure 2A ), which could possibly be further enhanced by a dexOx chain coil due to the intra hemiacetal formation ( Figure 1B ), demonstrating how both parameters (OD and Mw) can interfere on the viscosity of a given dexOx solution.
Hydrogels characterization
The hydrogels preparation took into consideration three factors: the dexOx concentration/oxidation degree and the AAD concentration. The first two are closely related due to the viscosity issues that were discussed above. Therefore, the concentration used was as high as the viscosity would allow it.
Solutions of D5 and D10 with 30% concentration allow a good homogenization, despite the high viscosity, but for D25, we had to use a 20% concentration. The D40 macromonomer was not studied in deep detail as the others, due to its high reactivity for the concentration range wanted. The D40 with a 20% concentration yields a very viscous solution that reacts promptly with AAD, impairing a good homogenization. Lower concentrations produce nicer hydrogels, however with less attractive and more unpredictable swelling profiles. Yet, the D40 gelation rate data is presented (15% feed concentration), to strengthen the issue on the balance between OD and AAD feed concentration effect on the gelation rate, discussed below.
The balance between the available crosslinking points (oxidation degree) and the amount of crosslinker used (AAD feed concentration) clearly affects the gelation rate, as shown on Table 2 , however, not always on the same direction. The gelation periods of D25 and D40 hydrogels decrease with the AAD increase, while for the D5 and D10 hydrogels, the gelation periods increase directly with the AAD concentration. When low OD's are present, the excess AAD increases the number of non-valid crosslinks, caused by the reaction of a single hydrazide, leaving a dangling end 25 , and retarding the hydrogel formation. The polymer feed concentration also affects the gelation periods, as can be observed with the D40 hydrogels, which should be faster than the D25, for the same AAD feed concentrations.
The dexOx/AAD hydrogels were prepared in Teflon molds and let to cure for at least two hours, except for the D5 hydrogels, which were left overnight, due to the slow curing rate. Equal volumes of dexOx and AAD solutions were added and mixed vigorously with the pipette tip, to achieve a good homogenization of both solutions.
The hydrazide groups in AAD react with the aldehyde groups in oxidized dextrans forming hydrazone bonds, which are hydrolysable, retrieving the same chemical groups ( Figure 1C) , therefore, making these hydrogels soluble in different time frames. The swelling index (Equation 1) of the different sets of hydrogels showed how the dissolution profiles could be controlled, not only by the AAD amount but as well by the dextran OD. By increasing the OD, we can significantly increase the dissolution time of the hydrogels. This oxidation increase, allows that more AAD can be used as a crosslinking agent, reflecting on more lasting hydrogels. By balancing these two variables it is possible to control the dissolution profile of the hydrogels.
As shown, low oxidation degrees do not allow long dissolution times. However, it is perfectly possible to control the dissolution profile with the AAD concentration, within a range of 5 days (Box in Figure 3 ). Rising up the oxidation, hydrogels more resistant to dissolution are obtained. The D25 hydrogels have very interesting profiles ( Figure 3 ). The dissolution time could be extended up to 70 days. Furthermore, one can observe an interesting plateau, with 20% AAD, resembling a saddle, approximately from the 2 nd until the 50 th day of immersion on phosphate buffer. Within this period the hydrogels maintained their size and shape without abrupt swelling variations. This profile seems to be interesting for the proposed application, as it will not swell above the injected volume and takes few weeks to dissolve. Just before the hydrogel collapses and dissolve, a maximum swelling peak is observed. We hypothesize this peak to be a fracture point, reached when the osmotic force equals the polymeric matrix force, which weakens through time, due to the AAD diffusion out of the hydrogel.
The water content of the vitreous humour is around 98%, mainly composed of collagen, hyaluronic acid 26 and hyalocytes of Balazs, which take care of removing cellular debris and reprocessing the hyaluronic acid 27 . Since the dexOx hydrogels are soluble in water and electrolyte solutions we think that the vitreous humour will naturally contribute to the dissolution of the hydrogel and help the hydrogel elimination. The by products of the designed hydrogel are its same initial components.
Oxidized dextran and AAD. Both by-products should be excreted, to the aqueous humor, by the anterior route. This elimination is probably faster than through the blood-retina barrier to the systemic circulation 1 , despite that dextrans, up to 150 kDa, are diffusible through the sclera 28 .
Assessment of Cytotoxic Potential.
The characteristics of these formulations render them suitable as a drug carrier to the posterior part of the eye, due to its injectable character, the controlled gelation rate or the dissolution profile shown.
Formulations composed partially by dexOx have been tested for their biocompatibility. Recently, Bhatia and co-workers 17 , seeded 3T3 fibroblast cells on top of oxidized dextran (20% -50% OD) crosslinked with 8-arm PEG amine and showed that their formulation, was non-toxic and could lead to cell confluence after 24 hours of growth. This suggests, that the crosslinked-oxidized dextran can promote better cell adhesion than dextran itself 29 , despite showing some toxicity when present, alone, in cell culture with mesothelial cells 30 .
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In the present work, endothelial cells from rabbit cornea were chosen based on the need to assess the oxidized dextran AAD crosslinked hydrogels cytotoxicity for the proposed application.
To assess the cytotoxicity of these materials, several combinations of hydrogels involving the different dexOx's and AAD concentrations, were prepared. The 96-well cell culture plates were covered with 60 !L of hydrogels or just controls and the cells were seeded on top, after an over-night curing period. The materials used were not only dissolved in PBS but also on the appropriate cell culture media. Occasionally, the initial dexOx feed concentration had to be slightly decreased, due to the high viscosity, probably due to medium proteins, that crosslink with the oxidized dextran through the existing amine groups.
After cell seeding on top of the hydrogels, each well was visualized in optical microscope, to observe whether there was any cell adhesion and/or proliferation. Cells grew in the presence of all hydrogels tested, although cell growth, in the presence of D25 hydrogels, did not achieve confluence during the period of study (Figure 4 ).
Dextran is neutrally charged and we expect dexOx to keep the neutrality, as the periodate oxidation reaction does not yield any charged chemical groups. However, the crosslinking of dexOx with AAD (pKa 2.5) yields hydrazone bonds which were reported to have a pKa in the order of 3 to 4 31 . Hence, due to the nature of the crosslinking bond, we suggest that the hydrogels zeta potential shifts negatively, allowing cell growth and proliferation.
It is well known that the surface chemistry of hydrogels can affect cell adhesion, proliferation and other phenomena. Chen et al 32 work showed how the polymer nature and crosslinker concentration can dictate the surface charge density of the gels and strongly influence the cell behaviour. They have identified a threshold on the surface zeta potential (-20 mV), below which cell adhere and proliferate.
Schneider and collaborators also reported that charge density of the hydrogel can regulate cell attachment either directly in the absence of extracellular matrix components, or indirectly through the association of extracellular matrix proteins found within the serum associated with charges of the hydrogel surface 33 .
The MTS assay is a quick effective method for testing mitochondrial impairment and correlates quite well with cell proliferation. In recent years, it has been frequently used as a preliminary screen for the evaluation of in vitro cytotoxicity of polymeric components.
The MTS assays were performed at 1, 3 and 7 days after cells being seeded on top of the hydrogels.
Cellular activity did not seem to be affected by the medium used to prepare the hydrogels (MEM or PBS). The results ( Figure 5 ) emphasize that every formulation promoted dehydrogenase activity. In the first 24 hours, all hydrogels promoted higher enzyme activity than the negative control. By the 3 rd day, the activity doubled for most hydrogels, with a few exceptions, and by the 7 th day, the activity maintained the same levels. These results demonstrate the tested formulations as non-cytotoxic.
Conclusions
On the estimation of the dextran oxidation degree, we have identified ethyl carbazate as a better and more accurate titrant, than tert-butyl carbazate, especially for the higher oxidized samples. The bulkier tBC moiety causes sample precipitation and it also seems to impair good access to the oxidized residues lowering the measured oxidation degree.
The viscosity studies revealed how the dextran oxidation degree can limit the concentration used.
However, for diluted dexOx solutions, the lower molecular weight, counter-balances the oxidation effect, decreasing the viscosity.
The characterized hydrogels have a dual crosslinking control method, which lies on the dextran OD and the amount of AAD used. The OD allows a given percentage of residues to serve as reactive points to molecules such as AAD. The amount of AAD used is crucial in defining the gelation period, mechanical properties and dissolution profile of the hydrogels. It should be within the same range of the amount of oxidized residues present in dextran, to avoid forming dangling ends, and not valid mechanical crosslinks.
On the cytotoxicity assay, the different dextran oxidation degrees tested were successful in promoting cell adhesion and growth. However, with the increasing oxidation, the cells took longer to proliferate in the hydrogels. Oddly, the metabolic activity, measured by the MTS assay, showed very high levels of activity for the higher oxidized hydrogels, not corresponding to the cellular proliferation observed.
The proposed and studied system aims at providing a sustainable drug delivery device to the posterior part of the eye, which requires a single injection, but does not require further surgery on the removal of the device. The designed formulation is expected to dissolve and be eliminated naturally by the organism. 
